YOLFTbeta
Rua Life Sciences PLC

Rua Life Sciences PLC

RUA · LSE · Healthcare / Medical Devices

22.50GBX+0.00 (0.00%)

Price History

Full chart

Market Stats

Previous Close22.50
Open22.50
Day Range21.71 – 23.34
52-Week Range10.50 – 31.00
Volume100.97K
Market Cap17.69M
P/E (TTM)0.00
Forward P/E16.89
EPS0.00
Dividend Yield0.00%
Beta0.99
50-Day Avg26.85
200-Day Avg19.52

About

RUA Life Sciences plc, together with its subsidiaries, develops medical devices in Europe, North America, the Middle East, the Asia Pacific, and Africa. It operates through four segments: Biomaterials, Contract Manufacture, Vascular, and Structural Heart. The company acts as the depository of intellectual property and licensing rights to various biostable and implantable polymers, including Elast-Eon and ECSil; and provides sub-contract manufacturing, assembly, packing, and services of medical device, as well as implantable fabric. It also engages in the development and commercialization of bore polymer sealed grafts and soft tissue patches; and development of tri-leaflet polymeric heart valves. The company was formerly known as AorTech International plc and changed its name to RUA Life Sciences plc in June 2020. RUA Life Sciences plc was incorporated in 1996 and is headquartered in Irvine, the United Kingdom.

Company Details

  • SectorHealthcare
  • IndustryMedical Devices
  • CEOMr. William Donald Brown
  • Employees59
  • Headquarters2 Drummond Crescent, Irvine, United Kingdom, KA11 5AN, UK
  • Websitehttps://rualifesciences.com

Leadership

  • Mr. William Donald BrownChief Executive Officer & Director · b. 1963
  • Mr. Lachlan Arthur SmithCFO, Company Secretary & Director · b. 1980

Financials

Income Statement

Currency: GBP1994-03-311995-03-311996-03-311997-03-311998-03-311999-03-312000-03-312001-03-312002-03-312003-03-312004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312025-09-302026-03-31
Total Revenue966.00K958.00K1.75M2.17M1.80M2.78M3.45M3.70M4.63M1.38M360.00K137.00K1.43M276.00K1.48M1.26M1.36M1.57M3.15M2.50M251.38K576.86K625.56K490.03K404.00K463.00K489.00K1.53M1.63M2.18M2.19M4.11M4.46M4.46M
Growth (%)--0.83%+82.57%+24.24%-17.12%+54.30%+24.22%+7.21%+25.02%-70.20%-73.89%-61.94%+940.15%-80.63%+437.68%-15.16%+8.18%+15.27%+100.43%-20.63%-89.94%+129.48%+8.44%-21.67%-17.56%+14.60%+5.62%+212.47%+6.35%+34.09%+0.55%+87.72%+8.42%0.00%
Cost of Revenue-----1.24M1.36M2.00M2.56M1.07M31.00K31.00K223.00K158.00K205.00K124.00K382.00K357.00K437.85K1.35M--207.15K224.15K--0548.00K580.00K746.00K475.00K941.00K1.40M1.40M
Gross Profit966.00K958.00K1.75M2.17M1.80M1.54M2.09M1.70M2.07M312.00K329.00K106.00K1.20M118.00K1.28M1.14M980.00K1.21M2.71M1.15M251.38K576.86K418.41K265.88K404.00K463.00K489.00K980.00K1.04M1.43M1.72M3.17M3.06M3.06M
Gross Margin100.00%100.00%100.00%100.00%100.00%55.42%60.63%45.85%44.76%22.63%91.39%77.37%84.35%42.75%86.19%90.15%71.95%77.26%86.09%45.88%100.00%100.00%66.89%54.26%100.00%100.00%100.00%64.14%64.31%65.76%78.32%77.12%68.56%68.56%
Operating Expense542.00K1.17M2.00M3.21M2.42M2.56M3.93M8.68M4.61M28.70M2.53M2.19M1.87M2.35M2.65M2.67M3.04M3.80M2.69M352.12K659.94K745.80K817.63K464.61K693.00K1.09M1.48M2.78M3.40M3.74M3.65M4.16M3.88M3.88M
Operating Income424.00K-211.00K-251.00K-1.04M-617.00K-1.02M-1.83M-6.99M-2.54M-28.39M-2.20M-2.08M-665.00K-2.23M-1.37M-1.54M-2.06M-2.59M23.73K793.74K-408.56K-168.95K-399.22K-198.73K-289.00K-632.00K-991.00K-1.80M-2.35M-2.31M-1.94M-989.00K-826.67K-826.67K
Operating Margin43.89%-22.03%-14.35%-47.91%-34.26%-36.85%-53.10%-188.76%-54.94%-2058.74%-610.56%-1521.17%-46.67%-806.88%-92.52%-122.24%-151.17%-164.71%0.75%31.78%-162.53%-29.29%-63.82%-40.55%-71.53%-136.50%-202.66%-117.54%-144.74%-105.83%-88.41%-24.05%-18.54%-18.54%
EBITDA521.00K-120.00K-146.00K-914.00K-394.00K-731.00K-1.40M-5.59M744.00K12.83M-2.56M-1.92M-494.00K-1.84M-866.00K-1.24M-1.62M-1.67M237.98K-573.60K-270.58K12.12K-233.28K42.22K185.00K-391.00K-703.00K-1.28M-2.04M-1.95M-1.57M401.00K-383.33K-383.33K
EBITDA Margin53.93%-12.53%-8.35%-42.06%-21.88%-26.30%-40.47%-151.15%16.08%930.17%-710.28%-1398.54%-34.67%-665.58%-58.36%-98.09%-118.72%-106.24%7.56%-22.96%-107.64%2.10%-37.29%8.62%45.79%-84.45%-143.76%-83.70%-125.48%-89.40%-71.79%9.75%-8.60%-8.60%
Net Income348.00K-285.00K-362.00K-1.13M-594.00K-1.00M-1.76M-6.22M-12.88M-39.36M528.00K-1.87M-523.00K-2.12M-1.16M-1.25M-1.92M-2.50M35.60K-557.46K-493.76K-219.43K-419.36K-189.15K-34.00K-609.00K-816.00K-1.45M-2.07M-2.00M-1.44M1.00K-145.33K-145.33K
Net Income Margin36.02%-29.75%-20.70%-52.14%-32.98%-36.02%-51.10%-168.20%-278.45%-2854.10%146.67%-1362.77%-36.70%-768.48%-78.10%-99.21%-141.19%-159.30%1.13%-22.32%-196.42%-38.04%-67.04%-38.60%-8.42%-131.53%-166.87%-94.96%-127.20%-91.92%-65.72%0.02%-3.26%-3.26%
R&D---3.00K-680.00K1.56M--4.18M98.00K654.00K634.00K821.00K1.02M1.04M1.12M1.33M498.44K157.30K6.60K42.41K50.68K66.24K66.00K59.00K34.00K573.00K928.00K1.09M887.00K---
R&D as % of Total Revenue---0.14%-24.47%45.25%--303.26%27.22%477.37%44.49%297.46%68.94%82.61%82.31%84.90%15.84%6.30%2.63%7.35%8.10%13.52%16.34%12.74%6.95%37.50%57.11%49.84%40.48%---
Interest Expense51.00K99.00K111.00K104.00K58.00K60.00K45.00K25.00K000003.00K000001.35M35.45K020.18K00030.00K43.00K8.00K16.00K83.00K---
Interest Expense % of Total Revenue5.28%10.33%6.35%4.79%3.22%2.16%1.30%0.68%0.00%0.00%0.00%0.00%0.00%1.09%0.00%0.00%0.00%0.00%0.00%54.10%14.10%0.00%3.23%0.00%0.00%0.00%6.13%2.81%0.49%0.73%3.79%---

Balance Sheet

Currency: GBP1994-03-311995-03-311996-03-311997-03-311998-03-311999-03-312000-03-312001-03-312002-03-312003-03-312004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312025-09-302026-03-31
Total Assets2.08M1.94M2.06M4.66M3.90M5.43M44.37M38.48M48.84M9.24M8.01M6.00M5.76M3.68M7.84M6.72M6.04M3.78M3.57M3.06M1.95M1.78M1.34M1.13M1.08M3.10M2.49M10.15M7.63M5.66M8.17M9.26M9.12M-
Total Liabilities1.75M1.90M1.39M1.54M1.38M1.32M2.81M2.52M2.63M2.33M438.00K348.00K652.00K716.00K728.00K591.00K623.00K660.00K387.88K355.41K299.38K164.91K114.56K81.41K67.00K99.00K219.00K1.65M1.04M980.00K987.00K1.86M1.89M-
Total Equity330.00K44.00K678.00K3.12M2.52M4.11M41.55M35.96M46.21M6.91M7.57M5.65M5.11M2.96M7.11M6.13M5.41M3.12M3.18M2.71M1.65M1.61M1.22M1.05M1.02M3.00M2.27M8.51M6.58M4.68M7.18M7.30M7.14M-
Cash2.00K22.00K63.00K2.32M366.00K577.00K16.03M8.33M16.56M6.85M5.97M4.01M2.72M1.48M5.35M4.18M2.88M1.38M1.20M649.60K385.17K242.32K218.01K90.98K422.00K2.41M1.98M6.29M2.96M1.48M3.93M3.57M3.25M-
Total Debt-1.51M1.00M707.00K681.00K525.00K489.00K12.00K-------------------410.00K344.00K475.00K389.00K1.03M794.00K-
Net Debt-2.00K1.49M939.00K-1.61M315.00K-52.00K-15.54M-8.31M-16.56M-6.85M-5.97M-4.01M-2.72M-1.48M-5.35M-4.18M-2.88M-1.38M-1.20M-649.60K-385.17K-242.32K-218.01K-90.98K-422.00K-2.41M-1.98M-5.88M-2.62M-1.01M-3.54M-2.54M-2.46M-

Cash Flow

Currency: GBP1994-03-311995-03-311996-03-311997-03-311998-03-311999-03-312000-03-312001-03-312002-03-312003-03-312004-03-312005-03-312006-03-312007-03-312008-03-312009-03-312010-03-312011-03-312012-03-312013-03-312014-03-312015-03-312016-03-312017-03-312018-03-312019-03-312020-03-312021-03-312022-03-312023-03-312024-03-312025-03-312025-09-30
Operating Cash Flow-36.00K-233.00K446.00K-956.00K-1.37M-1.44M-2.02M-4.28M-12.99M-11.93M-971.00K-2.12M-1.29M-816.00K-1.14M-1.39M-2.05M-1.53M50.59K346.19K-24.00K-189.82K84.70K-159.62K347.00K-429.00K-431.00K-1.42M-2.36M-1.17M-1.33M-219.00K-137.00K
Investing Cash Flow-271.00K-28.00K-107.00K-2.02M1.52M-1.49M-18.20M5.92M-11.32M9.04M857.00K2.18M1.68M-420.00K-98.00K56.00K34.00K-47.00K-237.98K394.24K-263.38K--116.64K-16.00K-16.00K-133.00K-5.00K-943.00K-904.00K-449.00K-85.00K70.00K-59.00K
Financing Cash Flow-293.00K2.00K503.00K3.48M-95.00K2.64M20.32M-1.46M24.19M----75.00K4.90M--568.09K0-1.26M-57.84K--2.55M2.55M2.55M2.55M6.68M-66.00K132.00K3.89M-196.00K-459.00K
Capital Expenditure280.00K28.00K107.00K48.00K494.00K376.00K331.00K1.92M3.03M736.00K15.00K28.00K119.00K420.00K312.00K234.00K102.00K132.00K449.72K54.63K263.74K0111.54K1.00K16.60K1.00K5.00K620.00K904.00K449.00K55.00K62.00K161.00K
Free Cash Flow-316.00K-261.00K339.00K-1.00M-1.86M-1.81M-2.36M-6.21M-16.02M-12.67M-986.00K-2.15M-1.41M-1.24M-1.45M-1.62M-2.15M-1.66M-399.13K291.56K-287.74K-189.82K-26.84K-159.62K330.40K-430.00K-436.00K-2.04M-3.27M-1.62M-1.38M-281.00K-298.00K
FCF to OCF877.78%112.02%76.01%105.02%136.06%126.18%116.35%144.84%123.32%106.17%101.54%101.32%109.24%151.47%127.39%116.85%104.98%108.64%-788.90%84.22%1199.02%100.00%-31.69%100.00%95.22%100.23%101.16%143.57%138.29%138.25%104.14%128.31%217.52%

Earnings

Report DateNov 27, 2015Sep 19, 2016Dec 21, 2016Aug 31, 2017Dec 18, 2017Aug 14, 2018Nov 22, 2018Aug 15, 2019Nov 29, 2019Jul 13, 2020Dec 11, 2020Jul 12, 2021Dec 13, 2021Jul 18, 2022Dec 12, 2022Jul 26, 2023Dec 11, 2024Jun 15, 2025Jan 25, 2027
EPS Estimate0.000.000.000.000.000.000.000.000.000.00-----0.000.00--
EPS Actual-0.12-0.01-0.060.01-0.020.01-0.02-0.03-0.01-0.04-0.04-0.04-0.06-0.03-0.050.000.01-0.01-
Surprise-------------------
Timing-------------After-hoursPre-marketPre-market-Pre-marketPre-market

Key Statistics & Ratios

Market Cap17.69M
Enterprise Value15.66M
Trailing P/E0.00
Forward P/E16.89
Price / Sales3.83
Price / Book2.48
EPS0.00
Book Value0.113
Revenue (TTM)4.62M
Gross Profit (TTM)3.61M
EBITDA575.00K
Profit Margin6.10%
Operating Margin-8.52%
Return on Equity0.01%
Return on Assets-0.14%
Shares Outstanding62.06M
Shares Float50.42M
Beta0.99
Dividend Yield0.00%
Dividend Rate0.00
Payout Ratio0.00%

Stock Splits

  • Sep 1, 20031:10